ADGRG.ORG: Keyword Density Checker

Total words: 1753 | 2-word phrases: 461 | 3-word phrases: 491 | 4-word phrases: 500

PAGE INFO

Title	Try to keep the title under 60 characters (56 characters) Adhesion GPCR Research Group – seeing is believing
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	adhesion gpcr research	3	0.61%
2	gpcr research group	3	0.61%
3	resonance energy transfer	2	0.41%
4	using adgrg1gpr56 adgre2emr2	2	0.41%
5	adgrd1gpr133 and adgrg5gpr114	2	0.41%
6	of the human	2	0.41%
7	our research group	2	0.41%
8	skip to content	1	0.20%
9	novel therapeutic agents	1	0.20%
10	multiple functional domains	1	0.20%
11	ntf that carry	1	0.20%
12	fragment ntf that	1	0.20%
13	nterminal fragment ntf	1	0.20%
14	large nterminal fragment	1	0.20%
15	have large nterminal	1	0.20%
16	gpcrs have large	1	0.20%
17	potential to lead	1	0.20%
18	lead novel therapeutic	1	0.20%
19	to lead novel	1	0.20%
20	domains including the	1	0.20%
21	the potential to	1	0.20%
22	with the potential	1	0.20%
23	will provide insights	1	0.20%
24	pathways will provide	1	0.20%
25	signaling pathways will	1	0.20%
26	downstream signaling pathways	1	0.20%
27	the downstream signaling	1	0.20%
28	elucidating the downstream	1	0.20%
29	functional domains including	1	0.20%
30	conserved gain domain	1	0.20%

#	Keyword	Frequency	Density
1	adhesion gpcr research group	3	0.60%
2	2024 adhesion gpcr research	1	0.20%
3	the downstream signaling pathways	1	0.20%
4	adhesion gpcrs have large	1	0.20%
5	lead novel therapeutic agents	1	0.20%
6	to lead novel therapeutic	1	0.20%
7	potential to lead novel	1	0.20%
8	the potential to lead	1	0.20%
9	with the potential to	1	0.20%
10	pathways will provide insights	1	0.20%
11	signaling pathways will provide	1	0.20%
12	downstream signaling pathways will	1	0.20%
13	elucidating the downstream signaling	1	0.20%
14	have large nterminal fragment	1	0.20%
15	of activation interactome and	1	0.20%
16	mechanisms of activation interactome	1	0.20%
17	their mechanisms of activation	1	0.20%
18	understanding their mechanisms of	1	0.20%
19	important drug targets hence	1	0.20%
20	potentially important drug targets	1	0.20%
21	of potentially important drug	1	0.20%
22	class of potentially important	1	0.20%
23	a class of potentially	1	0.20%
24	gpcrs have large nterminal	1	0.20%
25	large nterminal fragment ntf	1	0.20%
26	agpcrs represent a class	1	0.20%
27	conserved gps site on	1	0.20%
28	ctf which is composed	1	0.20%
29	ntf and cterminal fragment	1	0.20%
30	into ntf and cterminal	1	0.20%
31	domain into ntf and	1	0.20%
32	gain domain into ntf	1	0.20%
33	the gain domain into	1	0.20%
34	on the gain domain	1	0.20%
35	site on the gain	1	0.20%
36	gps site on the	1	0.20%
37	autoproteolytically cleaved from the	1	0.20%
38	nterminal fragment ntf that	1	0.20%
39	are autoproteolytically cleaved from	1	0.20%
40	agpcrs are autoproteolytically cleaved	1	0.20%

#	URL	Whois	Check
1	http://kokens.ankara.edu.tr/en/mainpage/	Whois	edu.tr
2	https://www.ankara.edu.tr/en/	Whois	edu.tr
3	http://www.metu.edu.tr	Whois	edu.tr
4	https://www.adhernrise.eu	Whois	adhernrise.eu
5	https://www.adhesiongpcr.org	Whois	adhesiongpcr.org
6	https://twitter.com/adhesionGPCR	Whois	twitter.com